Key facts
- This page summarizes Heidi Fields's Form 3 filing for Icosavax, Inc..
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Jul 2021, 21:24.
Heidi Fields - 28 Jul 2021 Form 3 Insider Report for Icosavax, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 28 Jul 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Jul 2021, 21:24:54 UTC
- Prior SEC filing
- 24 May 2021
- Next SEC filing
- 02 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Russo, Attorney-in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Heidi Fields filed Form 3 for Icosavax, Inc. on 28 Jul 2021.
Change
- Previous filing in this sequence was filed on 24 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICVX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 28 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,266
- Exercise price
- $7.44
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
1/36th of the shares subject to the option vest monthly following May 29, 2021, the vesting commencement date.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney